Control of leukocyte integrin activation
- PMID: 7903025
- DOI: 10.1164/ajrccm/148.6_Pt_2.S55
Control of leukocyte integrin activation
Abstract
The integrin receptors on leukocytes are transiently activated by "triggering" molecules that may be other leukocyte membrane structures such as the T-cell receptor complex or small molecules such as PAF, which bind to their own specific receptors. This "inside out" signaling is essential for high affinity integrin/ligand pairing. In the example of LFA-1/ICAM-1, binding is positively supported by Mg2+ but negatively supported by Ca2+. How specific divalent cations affect receptor activation and subsequent ligand binding has still to be fully understood. However, the fact that activation can be mimicked from outside the cell via special anti-LFA-1 monoclonal antibodies such as MEM-83 suggests that activated integrins undergo conformational changes. Further alteration occurs as a result of the interaction of integrin with ligand, and the resulting novel epitopes are named "ligand-induced binding sites." For a brief period of time the integrin/ligand complex is able to transmit signals from "outside in." The transient activation of leukocyte integrins determines that cell-cell adhesion will be short lived and serves the purpose of permitting recycling of effector cells with their targets.
Similar articles
-
Analysis of ligand-induced and ligand-attenuated epitopes on the leukocyte integrin alpha4beta1: VCAM-1, mucosal addressin cell adhesion molecule-1, and fibronectin induce distinct conformational changes.J Immunol. 1998 May 1;160(9):4508-17. J Immunol. 1998. PMID: 9574557
-
Leukocyte integrin activation.Pathol Biol (Paris). 1992 Oct;40(8):785-8. Pathol Biol (Paris). 1992. PMID: 1362459 Review.
-
A novel anti-CD18 mAb recognizes an activation-related epitope and induces a high-affinity conformation in leukocyte integrins.Immunobiology. 2001 May;203(4):687-98. doi: 10.1016/S0171-2985(01)80017-6. Immunobiology. 2001. PMID: 11402502
-
T cell adhesion to intercellular adhesion molecule-1 (ICAM-1) is controlled by cell spreading and the activation of integrin LFA-1.J Immunol. 1996 Mar 1;156(5):1810-7. J Immunol. 1996. PMID: 8596031
-
Mechanisms contributing to the activity of integrins on leukocytes.Immunol Rev. 2002 Aug;186:164-71. doi: 10.1034/j.1600-065x.2002.18614.x. Immunol Rev. 2002. PMID: 12234370 Review.
Cited by
-
Changes in the phenotype of monocytes/macrophages and expression of cytokine mRNA in peripheral blood and synovial fluid of patients with rheumatoid arthritis.Clin Exp Immunol. 1995 Dec;102(3):541-6. doi: 10.1111/j.1365-2249.1995.tb03850.x. Clin Exp Immunol. 1995. PMID: 8536370 Free PMC article.
-
Leukotoxin (Leukothera®) targets active leukocyte function antigen-1 (LFA-1) protein and triggers a lysosomal mediated cell death pathway.J Biol Chem. 2012 May 18;287(21):17618-17627. doi: 10.1074/jbc.M111.314674. Epub 2012 Mar 30. J Biol Chem. 2012. PMID: 22467872 Free PMC article.
-
Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T Lymphocytes.Infect Immun. 2019 Jul 23;87(8):e00309-19. doi: 10.1128/IAI.00309-19. Print 2019 Aug. Infect Immun. 2019. PMID: 31109948 Free PMC article.
-
Cell-cell and cell-matrix adhesion molecules in human heart and lung transplants.Mol Cell Biochem. 1995 Jun 7-21;147(1-2):21-7. doi: 10.1007/BF00944779. Mol Cell Biochem. 1995. PMID: 7494550
-
Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA; Leukothera®): Mechanisms of Action and Therapeutic Applications.Toxins (Basel). 2019 Aug 26;11(9):489. doi: 10.3390/toxins11090489. Toxins (Basel). 2019. PMID: 31454891 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous